Friday, April 26, 2013

• Checking in on This Ex-Lehman Hedge Fund’s Favorite Equitiesat Motley Fool (Fri, Apr 26)
• Dr. Bassam Damaj, President and CEO of Innovus Pharmaceuticals, Inc. (INNV), Interviews with The Wall Street TranscriptWall Street Transcript (Fri, Apr 26)

Thursday, April 25, 2013

• Cancer Doctors Raise Pressure On Pharma Industry To Cut Drug Pricesat Forbes (Thu, Apr 25)
• Sanofi (SNY): Today's Featured Health Care Laggardat TheStreet (Thu, Apr 25)
• Questcor Pharmaceuticals: How Can Such A Profitable Company Be So Risky?at Seeking Alpha (Thu, Apr 25)
• Bristol-Myers Reports In Line EarningsZacks (Thu, Apr 25)
• InterMune Cuts Loss, Affirms ViewZacks (Thu, Apr 25)
• Doctors Denounce Cancer Drug Prices of $100,000 a Yearat New York Times (Thu, Apr 25)
• As Companies Abandon Cholesterol, An Old Player Re-Emergesat Forbes (Thu, Apr 25)
• Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC StudyBusiness Wire (Thu, Apr 25)

Wednesday, April 24, 2013

• 2 Orphan Drugmakers With Upcoming Catalystsat Motley Fool (Wed, Apr 24)
• Sanofi Reaches New 52-Week High (SNY)at TheStreet (Wed, Apr 24)
• European drug stocks on a tearat CNNMoney.com (Wed, Apr 24)

Tuesday, April 23, 2013

• Will Eli Lilly's Big Bets Pay Off?at Motley Fool (Tue, Apr 23)
• The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Eli Lilly, Gilead Sciences and Logitech InternationalZacks (Tue, Apr 23)
• U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosaPR Newswire (Tue, Apr 23)

Monday, April 22, 2013

• Potential 200% Return With Cellceutixat Seeking Alpha (Mon, Apr 22)
• Bristol-Myers Likely to Report In Line EarningsZacks (Mon, Apr 22)
• 4 Stocks Pushing The Drugs Industry Downwardat TheStreet (Mon, Apr 22)
• Sanofi's Vaccine Gets EU ApprovalZacks (Mon, Apr 22)
• Sanofi Stock Buy Recommendation Reiterated (SNY)at TheStreet (Mon, Apr 22)

Friday, April 19, 2013

• Investing in Potential Blockbustersat Motley Fool (Fri, Apr 19)
• Why Did Vanda Pharmaceuticals Hit A 52-Week High?at Seeking Alpha (Fri, Apr 19)

Thursday, April 18, 2013

• Genzyme Convenes 13th European Fabry Disease RoundtableBusiness Wire (Thu, Apr 18)

Wednesday, April 17, 2013

• Declines From Sanofi (SNY) Drive Down Drugs Industryat TheStreet (Wed, Apr 17)

Add SNY News to My Yahoo!